Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TripSitter ClinicXCNQ:KETA 20 EBIT per Share is C$-0.02 as of Oct. 2025. GuruFocus rates XCNQ:KETA with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 523 Healthcare Providers & Services companies, TripSitter Clinic ranks better than 92.54% on this metric.
TripSitter Clinic's EBIT per Share for the
three
months ended in Oct. 2025 was C$-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Oct. 2025 was C$-0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 64.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for TripSitter Clinic's EBIT per Share or its related term are showing as below:
XCNQ:KETA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -21.5 Med: 21.3 Max: 64.1
Current: 64.1
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of TripSitter Clinic was 64.10% per year. The lowest was -21.50% per year. And the median was 21.30% per year.
XCNQ:KETA's 3-Year EBIT Growth Rate is ranked better than 92.54% of 523
companies
in the Healthcare Providers & Services industry
Industry Median: 11.8
vs XCNQ:KETA: 64.10
TripSitter Clinic (XCNQ:KETA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
TripSitter Clinic EBIT per Share Related Terms
TripSitter Clinic EBIT per Share Historical Data
* Premium members only.
The historical data trend for TripSitter Clinic's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TripSitter Clinic (XCNQ:KETA) has a EBIT per Share of C$-0.02 as of Oct. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on TripSitter Clinic and its competitors. According to the industry distribution chart, TripSitter Clinic ranks #39 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 7.5%.
Is TripSitter Clinic's EBIT per Share too high?
TripSitter Clinic's current EBIT per Share is C$-0.02. Based on the distribution chart, TripSitter Clinic ranks #39 out of 523 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, TripSitter Clinic has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does TripSitter Clinic's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, TripSitter Clinic ranks #39 out of 523 companies for EBIT per Share. This places TripSitter Clinic in the top 8% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on TripSitter Clinic and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TripSitter Clinic's current EBIT per Share is C$-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TripSitter Clinic stock overvalued right now?
TripSitter Clinic (XCNQ:KETA) has a current EBIT per Share of C$-0.02. The current EBIT per Share is C$-0.02. TripSitter Clinic's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For TripSitter Clinic (XCNQ:KETA), the current EBIT per Share is C$-0.02 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TripSitter Clinic Ltd is a consultative virtual clinic and telehealth platform that connects prospective patients to a licensed physician in the United States who can evaluate for a prescribed treatment program of low-dose, oral ketamine medication. Its revenues are generated from the provision of initial consultations and monthly subscriptions to patients seeking mental health treatment that includes legal psychedelic medicine connected with licensed medical practitioners, and also it earns revenue from the sale of monthly subscription plans in the United States.
20GF Score
Get the complete analysis for XCNQ:KETA
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:KETA has been successfully added to your 
